{
    "table_name": "EBI_CHEMBL.MOLECULE_DICTIONARY_30",
    "table_fullname": "EBI_CHEMBL.EBI_CHEMBL.MOLECULE_DICTIONARY_30",
    "column_names": [
        "structure_type",
        "usan_substem",
        "indication_class",
        "pref_name",
        "availability_type",
        "chembl_id",
        "prodrug",
        "withdrawn_reason",
        "chirality",
        "withdrawn_year",
        "black_box_warning",
        "withdrawn_flag",
        "molregno",
        "withdrawn_country",
        "first_approval",
        "parenteral",
        "first_in_class",
        "oral",
        "usan_stem",
        "dosed_ingredient",
        "topical",
        "natural_product",
        "usan_stem_definition",
        "therapeutic_flag",
        "chebi_par_id",
        "inorganic_flag",
        "withdrawn_class",
        "molecule_type",
        "polymer_flag",
        "usan_year",
        "max_phase"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "NUMBER",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "NUMBER"
    ],
    "description": [
        "Indications whether the molecule has a small molecule structure or a protein sequence (MOL indicates an entry in the compound_structures table, SEQ indications an entry in the protein_therapeutics table, NONE indicates an entry in neither table, e.g., structure unknown)",
        "Where the compound has been assigned a USAN name, this indicates the substem",
        "Indication class(es) assigned to a drug in the USP dictionary",
        " Preferred name for the molecule",
        "The availability type for the drug (0 = discontinued, 1 = prescription only, 2 = over the counter)",
        "ChEMBL identifier for this compound (for use on web interface etc)",
        "Indicates that the molecule is a pro-drug (see molecule hierarchy for active component, where known)",
        "Reasons for withdrawl (e.g., safety)",
        "Shows whether a drug is dosed as a racemic mixture (0), single stereoisomer (1) or is an achiral molecule (2)",
        "Year the drug was first withdrawn in any country",
        "Indicates that the drug has a black box warning",
        "Flag indicating whether the drug has been withdrawn in at least one country (not necessarily in the US)",
        "Internal Primary Key for the molecule",
        "List of countries/regions where the drug has been withdrawn",
        "Earliest known approval year for the molecule",
        "Indicates whether the drug is known to be administered parenterally",
        "Indicates whether this is known to be the first compound of its class (e.g., acting on a particular target).",
        "Indicates whether the drug is known to be administered orally.",
        "Where the compound has been assigned a USAN name, this indicates the stem, as described in the USAN_STEM table.",
        "Indicates that the drug is dosed in this form (e.g., a particular salt)",
        "Indicates whether the drug is known to be administered topically.",
        "Indicates whether the compound is natural product-derived (currently curated only for drugs)",
        "Definition of the USAN stem",
        "Indicates that a drug has a therapeutic application (as opposed to e.g., an imaging agent, additive etc).",
        "Preferred ChEBI ID for the compound (where different from assigned)",
        "Indicates whether the molecule is inorganic (i.e., containing only metal atoms and <2 carbon atoms)",
        " High level categories for the withdrawn reason (e.g., Cardiotoxicity, Hepatotoxicity)",
        "Type of molecule (Small molecule, Protein, Antibody, Oligosaccharide, Oligonucleotide, Cell, Unknown)",
        "Indicates whether a molecule is a small molecule polymer (e.g., polistyrex)",
        "The year in which the application for a USAN/INN name was made",
        "Maximum phase of development reached for the compound (4 = approved). Null where max phase has not yet been assigned."
    ],
    "sample_rows": [
        {
            "molregno": 675363,
            "pref_name": "PEGFILGRASTIM",
            "chembl_id": "CHEMBL1201568",
            "max_phase": 4,
            "therapeutic_flag": 1,
            "dosed_ingredient": 1,
            "structure_type": "SEQ",
            "chebi_par_id": null,
            "molecule_type": "Protein",
            "first_approval": 2002,
            "oral": 0,
            "parenteral": 1,
            "topical": 0,
            "black_box_warning": 0,
            "natural_product": 0,
            "first_in_class": 0,
            "chirality": 1,
            "prodrug": 0,
            "inorganic_flag": 0,
            "usan_year": 2000.0,
            "availability_type": 1,
            "usan_stem": "-stim; peg-",
            "polymer_flag": 0,
            "usan_substem": "-stim (-grastim); peg-",
            "usan_stem_definition": "colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF); PEGylated compounds",
            "indication_class": null,
            "withdrawn_flag": 0,
            "withdrawn_year": null,
            "withdrawn_country": null,
            "withdrawn_reason": null,
            "withdrawn_class": null
        },
        {
            "molregno": 675366,
            "pref_name": "INSULIN LISPRO",
            "chembl_id": "CHEMBL1201538",
            "max_phase": 4,
            "therapeutic_flag": 1,
            "dosed_ingredient": 1,
            "structure_type": "SEQ",
            "chebi_par_id": null,
            "molecule_type": "Protein",
            "first_approval": 1996,
            "oral": 0,
            "parenteral": 1,
            "topical": 0,
            "black_box_warning": 0,
            "natural_product": 0,
            "first_in_class": 0,
            "chirality": 1,
            "prodrug": 0,
            "inorganic_flag": 0,
            "usan_year": 1994.0,
            "availability_type": 1,
            "usan_stem": null,
            "polymer_flag": 0,
            "usan_substem": null,
            "usan_stem_definition": null,
            "indication_class": "Antidiabetic",
            "withdrawn_flag": 0,
            "withdrawn_year": null,
            "withdrawn_country": null,
            "withdrawn_reason": null,
            "withdrawn_class": null
        },
        {
            "molregno": 675368,
            "pref_name": "INTERFERON ALFA-2B",
            "chembl_id": "CHEMBL1201558",
            "max_phase": 4,
            "therapeutic_flag": 1,
            "dosed_ingredient": 1,
            "structure_type": "SEQ",
            "chebi_par_id": null,
            "molecule_type": "Protein",
            "first_approval": 1986,
            "oral": 0,
            "parenteral": 1,
            "topical": 0,
            "black_box_warning": 1,
            "natural_product": 0,
            "first_in_class": 0,
            "chirality": 1,
            "prodrug": 0,
            "inorganic_flag": 0,
            "usan_year": 1987.0,
            "availability_type": 1,
            "usan_stem": null,
            "polymer_flag": 0,
            "usan_substem": null,
            "usan_stem_definition": null,
            "indication_class": "Antineoplastic; Biological Response Modifier",
            "withdrawn_flag": 0,
            "withdrawn_year": null,
            "withdrawn_country": null,
            "withdrawn_reason": null,
            "withdrawn_class": null
        },
        {
            "molregno": 675369,
            "pref_name": "SECRETIN SYNTHETIC HUMAN",
            "chembl_id": "CHEMBL1201488",
            "max_phase": 4,
            "therapeutic_flag": 1,
            "dosed_ingredient": 1,
            "structure_type": "SEQ",
            "chebi_par_id": null,
            "molecule_type": "Protein",
            "first_approval": 2004,
            "oral": 0,
            "parenteral": 1,
            "topical": 0,
            "black_box_warning": 0,
            "natural_product": 0,
            "first_in_class": 0,
            "chirality": 1,
            "prodrug": 0,
            "inorganic_flag": 0,
            "usan_year": NaN,
            "availability_type": 1,
            "usan_stem": "-retin",
            "polymer_flag": 0,
            "usan_substem": "-retin",
            "usan_stem_definition": "retinol derivatives",
            "indication_class": null,
            "withdrawn_flag": 0,
            "withdrawn_year": null,
            "withdrawn_country": null,
            "withdrawn_reason": null,
            "withdrawn_class": null
        },
        {
            "molregno": 675371,
            "pref_name": "ETANERCEPT",
            "chembl_id": "CHEMBL1201572",
            "max_phase": 4,
            "therapeutic_flag": 1,
            "dosed_ingredient": 1,
            "structure_type": "SEQ",
            "chebi_par_id": null,
            "molecule_type": "Protein",
            "first_approval": 1998,
            "oral": 0,
            "parenteral": 1,
            "topical": 0,
            "black_box_warning": 1,
            "natural_product": 0,
            "first_in_class": 0,
            "chirality": 1,
            "prodrug": 0,
            "inorganic_flag": 0,
            "usan_year": 1998.0,
            "availability_type": 1,
            "usan_stem": "-cept",
            "polymer_flag": 0,
            "usan_substem": "-cept (-nercept)",
            "usan_stem_definition": "receptor molecules, native or modified: tumor necrosis factor receptors",
            "indication_class": null,
            "withdrawn_flag": 0,
            "withdrawn_year": null,
            "withdrawn_country": null,
            "withdrawn_reason": null,
            "withdrawn_class": null
        }
    ]
}